CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
CARLSMED, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$13.66+0.25 (+1.86%)
Close on Oct 19, 2026
- Market cap
- $371.43M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.11 (+0.81%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
CARLSMED, INC. grew revenue 65.4% to $63.30M over the twelve months to Jun 30, 2026. Free cash flow was -$34.58M.
Revenue
$63.30M
+65.4% vs. a year earlier
Operating income
-$38.67M
TTM Q2 2026
Free cash flow
-$34.58M
TTM Q2 2026
EPS, diluted
-$2.12
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $371.43M
- P/E ratio
- –
- Price to sales
- 5.87
- Price to book
- 4.41
- Dividend yield
- –
- Free cash flow yield
- -9.31%
Fundamentals
- Revenue
- $63.30M
- Net income
- -$36.35M
- EPS, diluted
- -$2.12
- Free cash flow
- -$34.58M
- Book value per share
- $3.10
- Diluted shares
- 27M
Three years at a glance
Fiscal years 2023 to 2025 and trailing twelve months, USD
Revenue
$63.30M+65.4% YoY
Gross profit
$48.50M+71.2% YoY
Operating income
-$38.67M
Net income
-$36.35M
EPS, diluted
–
Free cash flow
-$34.58M
Reported periodTrailing twelve months